These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 9568680)

  • 21. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
    Tamori Y; Masugi J; Nishino N; Kasuga M
    Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.
    Masugi J; Tamori Y; Mori H; Koike T; Kasuga M
    Biochem Biophys Res Commun; 2000 Feb; 268(1):178-82. PubMed ID: 10652233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
    Satoh J
    Nihon Rinsho; 2003 Jul; 61(7):1224-9. PubMed ID: 12877089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiazolidinediones -- some recent developments.
    Stumvoll M
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1179-87. PubMed ID: 12831352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
    Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
    Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.
    Zieleniak A; Wójcik M; Woźniak LA
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipocyte differentiation is regulated by a prostaglandin liganded to the nuclear peroxisome proliferator-activated receptor.
    Wolf G
    Nutr Rev; 1996 Sep; 54(9):290-2. PubMed ID: 9009672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
    Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
    Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR(gamma) and glucose homeostasis.
    Picard F; Auwerx J
    Annu Rev Nutr; 2002; 22():167-97. PubMed ID: 12055342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
    Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
    Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of a thiazolidinedione compound as a new antidiabetic drug].
    Toyota T
    Nihon Rinsho; 2001 Nov; 59(11):2211-8. PubMed ID: 11712410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
    Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
    Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanisms of action of thiazolidinediones].
    Girard J
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):271-8. PubMed ID: 11452221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization.
    Saraf N; Sharma PK; Mondal SC; Garg VK; Singh AK
    J Pharm Pharmacol; 2012 Feb; 64(2):161-71. PubMed ID: 22221092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
    Wang M; Tafuri S
    J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glitazones: clinical effects and molecular mechanisms.
    Stumvoll M; Häring HU
    Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.
    Fajas L; Debril MB; Auwerx J
    J Mol Endocrinol; 2001 Aug; 27(1):1-9. PubMed ID: 11463572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dawn of the SPPARMs?
    Rangwala SM; Lazar MA
    Sci STKE; 2002 Feb; 2002(121):pe9. PubMed ID: 11867819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
    Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
    Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiazolidinediones--tools for the research of metabolic syndrome X.
    Komers R; Vrána A
    Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.